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Shigellae are sensitive indicator species for studying trends 
in the international transmission of antimicrobial-resistant 
Enterobacteriaceae. Orthodox Jewish communities (OJCs) 
are a known risk group for shigellosis; Shigella sonnei is cy-
clically epidemic in OJCs in Israel, and sporadic outbreaks 
occur in OJCs elsewhere. We generated whole-genome se-
quences for 437 isolates of S. sonnei from OJCs and non-
OJCs collected over 22 years in Europe (the United King-
dom, France, and Belgium), the United States, Canada, and 
Israel and analyzed these within a known global genomic 
context. Through phylogenetic and genomic analysis, we 
showed that strains from outbreaks in OJCs outside of Is-
rael are distinct from strains in the general population and 
relate to a single multidrug-resistant sublineage of S. sonnei 
that prevails in Israel. Further Bayesian phylogenetic analy-
sis showed that this strain emerged approximately 30 years 
ago, demonstrating the speed at which antimicrobial drug–
resistant pathogens can spread widely through geographi-
cally dispersed, but internationally connected, communities.
Antimicrobial-resistant (AMR) Enterobacteriaceae are recognized as a global public health threat (1,2). 
Understanding the emergence of these pathogens and 
tracking transmission across international borders is vi-
tal for informing public health surveillance, intervention, 
and management (3). Shigella spp. are Enterobacteriace-
ae that cause severe, acute diarrhea resulting in mortality 
rates second only to rotaviruses as known agents of diar-
rheal disease (4). Shigellae cause disease in both low- and 
high-income nations (5), and >10 organisms can initiate 
disease (6). Shigellae are also increasingly resistant to an-
timicrobial drugs (7–10). Because of the large global bur-
den of shigellosis, the low infective dose, highly visible 
disease syndrome, and ability to acquire AMR, shigellae 
are a relevant and sensitive indicator species for studying 
trends in the global transmission and emergence of AMR 
enteric bacteria.
Of the recognized Shigella spp., the distribution of S. 
sonnei makes it particularly relevant for studying interna-
tional transmission because it is the most commonly isolat-
ed species in middle- to high-income nations (5) and causes 
a substantial disease incidence in low-income nations; for 
example, 23.7% of all documented shigellosis cases caus-
ing moderate to severe diarrhea in children <5 years of age 
in Africa and Asia (11). Moreover, S. sonnei prevalence in-
creases as nations develop economically (12–15). To exam-
ine the underlying processes of such broad epidemiologic 
phenomena over medium- to long-term scales in bacterial 
populations, robust, high-resolution molecular subtyping is 
used. Subtyping of S. sonnei by using whole-genome se-
quencing has defined a global population structure that is 
divided into 4 lineages; the third lineage, global III, dis-
seminated globally after acquiring multidrug resistance 
(MDR) (16). This advanced subtyping and established 
global context was used to show that the rise of S. sonnei 
in Vietnam was attributable to the point introduction and 
subsequent expansion of a single sublineage in the 1980s 
(17), demonstrating the effectiveness of this approach for 
characterizing epidemiologic phenomena.
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Similarly, assessing the global burden of a wide-
spread pathogen such as S. sonnei calls for use of a patient 
group in which the effects of illness are international. One 
such risk group for S. sonnei is Orthodox Jewish com-
munities (OJCs) (5). These communities are highly sus-
ceptible to shigellosis because of densely populated living 
conditions, high numbers of young children per family, 
and intracommunity transfer facilitated by large holiday 
gatherings (18–20). S. sonnei shigellosis is highly endem-
ic to Israel; its incidence there since the early 1990s has 
primarily been driven by biennial epidemics within OJCs 
in Israel (primarily in the 0–4-year age group, in whom 
the incidence is ≈7 cases/1,000 population/y [19]). In ad-
dition to incidence in OJCs in Israel, outbreaks ranging 
in size from 27 culture-confirmed cases to >13,000 cases 
of S. sonnei shigellosis have been reported in OJCs in 
Europe and North America (18,20–24). These outbreaks 
are attributable to highly clonal organisms, determined by 
using pulsed-field gel electrophoresis (20,22,24) and, in 
the case of an outbreak in Belgium, linked to prevailing 
strains from Israel (22). Thus, characterizing the interna-
tional connectivity of OJC-associated S. sonnei represents 
an opportunity to assess the effects of travel- and com-
munity-based associations on the transmission of AMR 
Enterobacteriaceae.
We generated whole-genome sequences from >400 
clinical isolates of S. sonnei collected over 22 years from 
OJCs within Israel, OJCs outside of Israel, and non-OJCs 
in the United Kingdom. We then combined these data 
with the established genomic global context for S. sonnei. 
By analyzing phylogenetic relationships, we investigated 
the distinction of strains from OJC outbreaks from other 
locally circulating strains (i.e., among non-OJCs) and 
explored the possible epidemiologic relationship of out-
breaks in OJCs outside of Israel and endemic shigellosis 
in Israel. We also sought to determine the relationship of 
these epidemiologic processes with AMR determinants 
in S. sonnei.
Materials
We performed whole-genome sequencing on 437 S. sonnei 
isolates as part of this study. These isolates were from pa-
tients associated with OJCs outside of Israel (n = 171), from 
221 patients in Israel (200 OJC, 21 of unknown ethnicity), 
or from patients in the United Kingdom not associated with 
OJCs (n = 45) (online Technical Appendix 1, http://ww-
wnc.cdc.gov/EID/article/22/9/15-1953-Techapp1.xlsx). 
The isolates were collected from 6 countries (Israel, the 
United Kingdom, France, Belgium, the United States, and 
Canada) during 1992–2014 (Figure 1). The collection in-
cluded isolates from most previously reported OJC-asso-
ciated outbreaks of S. sonnei shigellosis; we defined cases 
as being OJC-associated separately for each public health 
agency (Table 1).
Samples from Israel
The 221 samples of S. sonnei in Israel were collected dur-
ing 1992–2014 in local hospital and health maintenance or-
ganization laboratories, including the national sentinel lab-
oratory-based surveillance program (19). As described by 
Cohen et al. (19), 90% of the S. sonnei shigellosis isolates 
collected in Israel are from Jewish patients, and the iso-
lates from Israel sequenced in this study were primarily (n 
= 200, 90%) derived from OJCs (online Technical Appen-
dix 2 Table 1, http://wwwnc.cdc.gov/EID/article/22/9/15-
1953-Techapp2.pdf).
Samples from Outside of Israel
United Kingdom
A total of 146 S. sonnei samples were used from the 
Gastrointestinal Bacteria Reference Unit at Public Health 
England (London, United Kingdom). These samples in-
cluded 22 from a small OJC-associated outbreak (23) and 
an additional 79 from outbreaks during 2006–2014 that 
were epidemiologically confirmed to be associated with 
OJCs by interviews and questionnaires as part of public 
Figure 1. Origin and year of 
collection for 437 clinical isolates 
collected and sequenced from 
different countries and patient 
communities as part of study of 
travel- and community-based 
transmission of multidrug-resistant 
Shigella sonnei among international 
OJCs.	Non-OJC	samples	were	
isolated from samples in the United 
Kingdom that were phage-type and 
temporally matched to isolates from 
OJCs in the United Kingdom (online 
Technical Appendix 2 Figure 1,  
http://wwwnc.cdc.gov/EID/
article/22/9/15-1953-Techapp1.pdf).	
OJCs, Orthodox Jewish communities.
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health investigations. Also included were a set of 45 iso-
lates from patients with no known OJC association (non-
OJC). These background isolates were contemporaneously 
collected and selected on the basis of phage typing; that is, 
including diverse phage types, but focused on representing 
phage types associated with OJC outbreaks (online Techni-
cal Appendix 2 Figure 1). 
France
A total of 64 isolates from OJC-associated outbreaks in 
France (21) were submitted to the French National Reference 
Center for E. coli, Shigella, and Salmonella at the Pasteur In-
stitute collected during 1996–2014. These isolates included 
those from a small OJC-associated outbreak in 2007 (21).
Belgium
Three S. sonnei isolates were provided from Belgium. 
These isolates were collected during a small OJC-associated 
outbreak in Antwerp in 2008 (22).
United States and Canada
Three representative isolates were collected during a large, 
homogenous, OJC-associated outbreak of S. sonnei. This 
outbreak occurred across the United States and Canada 
during 1994–1996 (24).
Comparison Dataset
We analyzed the clinical isolates of S. sonnei alongside 
an existing global dataset compiled by KE Holt et al. (n 
= 118) (online Technical Appendix 1) (16). In brief, this 
global context dataset comprises temporally (collected 
during 1943–2008, 70% collected after 1992) and geo-
graphically diverse (from 4 continents) S. sonnei isolates 
previously used to define the population structure of this 
pathogen. The dataset includes 1 sample collected in Is-
rael in 2003.
Methods
DNA was extracted at multiple sites by using the Wizard 
genomic DNA extraction kit (ProMega, Madison, WI, 
USA) according to manufacturer’s instructions. DNA was 
sequenced by using the MiSeq and HiSeq 2000 platforms 
(Illumina, San Diego, CA, USA) at multiple institutes ac-
cording to in-house protocols (online Technical Appen-
dix 1) (25–27). Sequencing data for all isolates described 
passed internal quality control and were assembled into 
<687 contiguous sequences with a total length of <5.0 MB. 
Sequence data are available in the European Nucleotide 
Archive (http://www.ebi.ac.uk/ena; accession numbers in 
online Technical Appendix 2).
Analysis of sequencing data was similar to that pre-
viously described (28). Multiple sequence alignment for 
phylogenetic analysis was generated by mapping to ref-
erence isolate S. sonnei Ss046 (GenBank accession no. 
CP000038), then masking mobile and repetitive elements 
(16) and stripping sites of recombination (29). Analysis 
of remaining variable sites was performed by using maxi-
mum-likelihood analysis in RAxML version 7.8.6 to create 
phylogenetic trees (30).
For isolates in the OJC-associated lineage for which 
the sampling date was known (n = 333; online Technical 
Appendix 1), BEAST version 1.8 software (http://beast.
bio.ed.ac.uk/) was used to estimate the emergence date of 
the lineage (31). Root-to-tip distances were generated by 
using Path-O-Gen version 1.4 (32). BEAST results shown 
are from 4 chains of 100 million Markov chain Monte 
Carlo generations run according to a general time revers-
ible plus gamma substitution model, with a relaxed normal 
clock and Bayesian Skyline Population model, previously 
used for this pathogen (16,17). Chains were sampled every 
1,000 generations with a 10% initial burn-in for root-height 
(time to most recent common ancestor) analysis. The maxi-
mum clade credibility tree was generated with a 10% burn-
in and sampling every 100,000 generations. These results 
were consistent with those generated similarly by using a 
constant population growth model (online Technical Ap-
pendix 2 Table).
De novo assembly, annotation, and antimicrobial re-
sistance gene detection in the isolates was done as previ-
ously described (28) (accession numbers for annotated 
 
 
 
Table 1. Origins of Shigella sonnei isolates used to track travel- and community-based transmission of multidrug-resistant Shigella 
sonnei among international Orthodox Jewish communities* 
Region/community Country Year(s) Details References No.	isolates 
Europe OJCs Belgium 2008 Outbreak (22) 3 
 France 1996–2014 Multiple outbreaks This study, (21) 64 
 United Kingdom  2006–2014 Multiple outbreaks This study, (23) 101 
Europe non-OJCs (controls) United Kingdom 2008–2014 Matched (time and phage-
type) non-OJC cases 
This study 45 
United States and Canada OJCs United States 1994–1995 Outbreak (24) 3 
Israel† Israel 2000–2014 Sentinel laboratory 
surveillance 
This study, (19) 221 
Global context Multiple 1943–2008 Used for background (16) 118 
Total 555 
*OJC, Orthodox Jewish communities. 
†90%	known	OJC	ethnicity. 
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draft genome assemblies in online Technical Appendix 
1). Contiguous sequences containing antimicrobial re-
sistance genes were extracted from assemblies and the 
presence of plasmid incompatibility groups on these 
contiguous sequences was determined by using Plasmid-
Finder (33). The presence of the Tn7/Int2 cassette was 
confirmed by mapping, and synteny detected by using 
ACT (34).
Results
To determine the relationships among S. sonnei from OJCs 
inside and outside of Israel, we constructed a phylogenetic 
tree including whole-genome sequence data from 437 iso-
lates of S. sonnei alongside the 118 isolates from the global 
context dataset (Table 1; Figure 2). This analysis showed 
the existence of a large, unique monophyletic sublineage 
(n = 396 isolates) of the global III lineage that was almost 
Figure 2. The OJC-associated 
lineage of multidrug-resistant 
Shigella sonnei in context with 
other global lineages. These 
background (non-OJC) isolates 
were contemporaneously 
collected and selected on the 
basis of phage typing; that is, 
including diverse phage types, 
but focused on representing 
phage types associated with OJC 
outbreaks. The midpoint rooted 
maximum-likelihood phylogenetic 
tree shows the relationships of 
437 sequences from study of 
travel- and community-based 
transmission of multidrug-resistant 
S. sonnei among international 
OJCs	compared	with	118	isolates	
from a global context database of 
previously	defined	lineages	of	S. 
sonnei. Lineages are labeled along 
branches. OJCs, Orthodox Jewish 
communities. Scale bar indicates 
single-nucleotide polymorphisms. 
An	expanded	version	of	this	figure	
with additional details is available 
online	(http://wwwnc.cdc.gov/EID/
article/22/9/15-1953-F2.htm).
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exclusively (388/396, 98%) composed of isolates from 
OJC-associated outbreaks and samples from persons in 
Israel (OJC-associated lineage; Figure 2; online Technical 
Appendix 2 Figure 2). This lineage contained nearly all iso-
lates (217/221, 98%) sequenced from Israel and collected 
during1992–2014 (Figure 2); 170/171 (99%) of those iden-
tified from samples collected during the same time frame 
from OJCs in the United States, Canada, France, Belgium, 
and the United Kingdom; and the 1 isolate from the global 
context dataset that originated in Israel (Figure 2; online 
Technical Appendix 1). The clustering of most (387/392, 
99%) of the strains from Israel and the other OJC-associat-
ed strains in the OJC-associated lineage is remarkable con-
sidering that the lineage represented approximately 10% 
of the diversity of the S. sonnei: the largest intra-lineage 
pairwise distance was 8.8-fold less in the OJC-associated 
lineage relative to the remainder of the tree (Figure 2).
The inclusion of isolates from patients in the United 
Kingdom that were not associated with OJCs provided 
further illumination of the association of this lineage 
with OJCs. These non-OJC samples were almost entirely 
(37/45, 82%) located outside the OJC-associated lineage, 
distributed elsewhere in the global III and II lineages (Fig-
ure 2). Ultimately, this resulted in a statistically significant 
association of lineage with sample designation (i.e., OJC 
or non-OJC) among UK isolates (p<0.0001 by Fisher exact 
test). This association correlated better with phylogenetic 
position than phage type, which was a comparatively poor 
indicator of genome level phylogeny (online Technical 
Appendix 2 Figure 3). The relative phylogenetic positions 
of non-OJC and OJC isolates from the United Kingdom 
when viewed in an international context, i.e., including the 
other strains (Figure 2) showed that strains from UK OJCs 
were more likely to be related to strains from Israel than to 
strains circulating in non-OJCs. For example, strains from 
OJCs sampled in the United Kingdom in 2014 were phylo-
genetically adjacent to strains from Israel sampled in 2014, 
rather than to non-OJC strains sampled in the United King-
dom in 2014 (Figure 2.)
Consistent with this finding, phylogenetic relation-
ships within the OJC-associated lineage were defined more 
by time than geography (Figure 2; online Technical Appen-
dix 2 Figures 2, 4) Bayesian phylogenetic analysis showed 
that the OJC-associated lineage emerged in 1988 (95% 
highest posterior distribution 1985–1990) (Figure 3). Since 
that time, contemporaneously collected isolates were phy-
logenetically proximate with subsequent evolution, result-
ing in strain replacement rather than coexistence over time 
(Figure 3; online Technical Appendix 2 Figure 2). Con-
trasting with the clear time signature in the lineage, geo-
graphic admixing of isolates occurred within the lineage 
(Figure 3). For example, >5 and 7 monophyletic clusters of 
isolates from OJC-associated outbreaks in France and the 
United Kingdom, respectively, were encompassed within 
the diversity of strains characterized in Israel (Figure 3). 
Samples from a single epidemiologic OJC-associated 
Figure 3.  The OJC-associated lineage of multidrug-resistant 
Shigella sonnei across time. The Bayesian-inferred phylogenetic 
tree shows the evolutionary relationships of 333 isolates (those 
for	which	a	fixed	date	was	available)	in	the	OJC-associated	
lineage	since	its	emergence	in	the	late	1980s.	Tree	tips	overlay	
the collection date of the isolates. OJCs, Orthodox Jewish 
communities.	An	expanded	version	of	this	figure	showing	
associated antimicrobial drug resistance is available online 
(http://wwwnc.cdc.gov/EID/article/22/9/15-1953-F3.htm).
Shigella sonnei among Orthodox Jewish Communities
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outbreak in Belgium were separated from each other by 44 
single-nucleotide polymorphisms, making them phyloge-
netically distinct (Figure 2; online Technical Appendix 2 
Figure 2). This finding is consistent with contemporane-
ous OJC-associated outbreaks in different geographic areas 
representing real-time transmission events.
Because of the potential consequences of this intercon-
tinental transmission to the transfer of AMR to S. sonnei, 
we determined the AMR characteristics of the OJC-associ-
ated lineage. We found that the lineage had a unique AMR 
profile relative to isolates outside of the OJC-associated 
lineage (Table 2). The OJC-associated lineage belonged 
to the global III lineage of S. sonnei, and every isolate in 
the OJC-associated lineage contained a Tn7/Int2 cassette 
that encoded the MDR thought to have facilitated the 
global dispersal of global III (16). This cassette contains 
the aadA1, sat2, and dfrA1 genes that confer resistance to 
aminoglycosides, streptothricin, and trimethoprim and was 
chromosomally integrated adjacent to the glmS gene in 
these isolates (indicating a single acquisition event). This 
region is identical to a Tn7-like island, also adjacent to 
the glmS gene, in the newly emerging Xv serotype of S. 
flexneri (reference strain 2002017 [35]; online Technical 
Appendix 2 Figure 5). No mutations known to confer qui-
nolone resistance were found in gyrA or parC sequences 
of isolates in the OJC-associated lineage, and no plasmid-
encoded quinolone resistance genes were detected (online 
Technical Appendix 1).
To consider AMR mechanisms that had potential to 
mobilize among bacteria, we further examined antimicro-
bial resistance genes that were inconsistently present (in 
5%–95% of isolates) (Figure 3; online Technical Appen-
dix 1; online Technical Appendix 2 Figure 2). The 7 genes 
found to be inconsistently present across the lineage were 
second copies of aadA1 present in some isolates; the ami-
noglycoside resistance–conferring strA and strB genes; 
the sulphonamide resistance genes sul1 and sul2; the tet-
racycline resistance gene tetA; and the ampicillin resis-
tance gene blaTEM (Figure 3; online Technical Appendix 2 
Figure 2). Attempts were made to determine the coinheri-
tance and genetic carriage elements of these genes (within 
the limitations of genome assembly). In isolates that had 
additional copies of aadA1, the gene was typically co-
inherited with the sul1 gene (Figure 3; online Technical 
Appendix 1; online Technical Appendix 2 Figure 2); this 
combination was found on plasmids of 2 different incom-
patibility groups, I1 and P, as well as on contiguous se-
quences where no plasmid incompatibility groups were 
identified, shown as unknown (Figure 3; online Technical 
Appendix 2 Figure 2). Similarly, strA, strB, and sul2 were 
frequently co-inherited and found on plasmids of 4 differ-
ent incompatibility groups. Isolates collected earlier in the 
lineage’s evolution tended to carry strA/strB/sul2 on B/O/
K/Z, Q1, and P incompatibility group plasmids, whereas 
later isolates carried the genes on I1 plasmids (Figure 3; 
online Technical Appendix 2 Figure 2). Similarly, the 
tetA gene appeared to have had 2 major introductions into 
the lineage, earlier on a P group plasmid and later on an 
I1 plasmid (Figure 3; online Technical Appendix 2 Fig-
ure 2). Last, blaTEM genes were found in 86% of isolates 
in the lineage, compared with 14% outside of the lineage 
(Table 2; online Technical Appendix 1); these genes 
were carried on plasmids of 5 different incompatibility 
groups, with sporadic coinheritance patterns with other 
resistance genes (Figure 3; online Technical Appendix 2 
Figure 2).
 
 
 
Table 2. Antimicrobial resistance determinants among isolates 
isolates sequenced in study of travel- and community-based 
transmission of multidrug-resistant Shigella sonnei among 
international OJCs* 
Antimicrobial 
resistance 
determinant 
Within OJC-
associated lineage,  
n	=	395 
Outside OJC-
associated lineage,  
n = 42 
bl2d_oxa1 0.00 0.02 
catA1 0.00 0.02 
tetB 0.00 0.05 
dfrA5 0.00 0.07 
bl2b_tem 0.00 0.00 
dfrA16 0.00 0.00 
aac3iia 0.01 0.00 
dfrA17 0.01 0.00 
bl2b_tem1 0.01 0.00 
mphA 0.02 0.00 
dfrA14 0.03 0.02 
sul1 0.12 0.07 
tetA 0.18 0.79 
strB 0.53 0.88 
sul2 0.53 0.90 
strA 0.53 0.88 
arnA 0.95 0.95 
mdtP 0.97 1.00 
mdtO 0.97 0.98 
mdtN 0.97 1.00 
bacA 0.99 0.98 
emrE 0.99 1.00 
mdfA 0.99 1.00 
mdtK 0.99 1.00 
aadA1 0.99 0.81 
macB 0.99 0.98 
mdtL 0.99 0.98 
mdtE 0.99 1.00 
mdtF 0.99 1.00 
mdtG 1.00 1.00 
mdtH 1.00 1.00 
dfrA1 1.00 0.90 
acrA 1.00 1.00 
acrB 1.00 1.00 
bcr 1.00 1.00 
bl1_ec 1.00 1.00 
ksgA 1.00 1.00 
tolC 1.00 1.00 
blaTEM† 0.86 0.14 
*Excludes global context isolates. OJC-associated lineage defined in 
Technical	Appendix	Figure	1	(http://wwwnc.cdc.gov/EID/22/9/15-1953-
Techapp1.pdf). OJC, Orthodox Jewish communities. 
†Detected separately. 
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Discussion
We used whole-genome sequencing to develop a high-res-
olution picture of the international transmission of S. son-
nei and its AMR determinants among OJCs over several 
decades. These analyses offer insight for the epidemiology 
of shigellosis inside and outside of Israel as well as for 
the broader transmission of AMR enteric pathogens. We 
showed that, in countries outside of Israel, outbreak strains 
in OJCs were distinct from strains circulating in the gen-
eral population and that OJC-associated strains were more 
closely affiliated with outbreaks associated with OJCs in 
other countries (irrespective of geographic distance) and 
strains circulating in Israel. Strains from Israel and strains 
from nearly all previously reported OJC outbreaks else-
where formed a distinct OJC-associated sublineage that 
emerged ≈30 years ago. Unlike other described emergent 
Shigella sublineages (17,28), the OJC-associated lineage 
lacked a defining association with AMR.
Isolates collected during outbreaks of S. sonnei in OJCs 
outside Israel were phylogenetically linked to contempo-
raneous isolates from Israel. This finding was suspected 
from previous studies that used pulsed-field gel electro-
phoresis, the results of which supported that samples from 
outbreaks among OJCs in the United States and Belgium 
were distinct from samples of S. sonnei circulating locally 
in non-OJCs (22,24) and were related to strains from Israel 
(22). We confirmed this link in an analysis of specimens 
collected in the United Kingdom that showed that strains 
from OJC-associated outbreaks were distinct from other 
circulating strains in that country but related to contempo-
raneous strains from Israel (Figure 2). The broader anal-
ysis, expanded in time and geography, showed that local 
epidemics in OJCs in France, Belgium, and North America 
(21,22,24) were also linked with contemporaneous isolates 
from Israel (Figure 3; online Technical Appendix 2 Figure 
2). This pattern of phylogenetic clustering by community 
affiliation was also recently demonstrated for S. flexneri 
3a strain transmission among a global epidemiologic com-
munity of men who have sex with men, through which a 
unique MDR sublineage spread during ≈20 years (28). 
These studies demonstrate the speed with which AMR En-
terobacteriaceae can be transmitted among persons in an 
internationally linked community rather than by contigu-
ous geographic spread.
These findings also have implications for the epide-
miology of shigellosis within Israel. The isolates from Is-
rael in this study derive primarily from OJCs, which drive 
cyclic S. sonnei epidemics in Israel (19); here, they were 
shown to belong to a single, low-diversity sublineage. The 
lineage was monophyletic and had a strong time signature, 
consistent with a point introduction and subsequent epi-
demic emergence. This pattern was similar to that observed 
in Vietnam after the introduction of another global III S. 
sonnei sublineage (15,17). The date of the emergence of 
the OJC-associated lineage (1988 [95% highest posterior 
distribution 1985–1990]) is consistent with that estimated 
in a previous study where a 2-isolate lineage emerged in 
the Middle East during 1983 (16). Considering the timing 
and context of the emergence, it is possible that the OJC-
associated lineage emerged from the large waterborne epi-
demic that occurred in Israel in the mid-1980s (19) or was 
potentially introduced from the first reported OJC-associat-
ed outbreak of shigellosis outside of Israel, which was an 
outbreak of >13,000 cases across the United States that also 
occurred in the 1980s (18). Samples from this period were 
not available to explore these origins of these outbreaks, 
but it is clear that the OJC-associated lineage is now en-
demic to OJCs in Israel and is causative of OJC-associated 
outbreaks elsewhere.
The AMR profile of the OJC-associated lineage is con-
sistent with the phenotypic information and is likely influ-
enced by antimicrobial resistance selection pressures in the 
0–4-year age group, which is primarily affected by shigel-
losis in OJCs. Sulfonamide and tetracycline resistance de-
terminants were in flux across the lineage (Figure 3), and 
these antimicrobial classes have been reported as being 
phenotypically dynamic over time among S. sonnei iso-
lated in Israel (19). Furthermore, trimethoprim resistance 
was chromosomally encoded in all isolates, and plasmid- 
mediated ampicillin resistance was a common finding (86% 
of isolates) (Figure 3). These antimicrobial classes are key 
for the treatment of children with shigellosis. Similarly, re-
sistance to tetracyclines, which can be used in children >7 
years of age (8), and macrolides (mphA gene [21]) (Table 
2) were also found. Despite being reported in other global 
III S. sonnei strains (16,17), resistance to quinolones was 
not found in the OJC-associated lineage, possibly because 
the use of quinolones is contraindicated in children.
The acquisition of the Tn7/Int2-encoded MDR in this 
lineage may have facilitated its epidemic emergence, as has 
been hypothesized for the broader global III lineage (16) 
and as is possible for S. flexneri Xv (35), although these 
possibilities cannot be explored fully by using these data. 
The presence of this gene cassette throughout the lineage 
and other phylogenetic clusters of antimicrobial resistance 
genes demonstrates that AMR can spread through this 
geographically dispersed, but closely associated, commu-
nity. However, in contrast to the emergence of S. flexneri 
3a among men who have sex with men or of S. sonnei in 
Vietnam, further acquisition of AMR does not appear to 
have shaped the subsequent evolution of the lineage. The 
presence of additional resistance genes (Figure 3) was not 
correlated with later time points, and the same genes were 
carried on distinct mobile genetic elements, consistent with 
sporadic reintroduction, rather than maintenance of the ad-
ditional resistance genes in the population. This absence of 
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a defining association with AMR suggests that it is prob-
ably primarily the epidemiologic suitability of OJCs to the 
transmission of S. sonnei that supports its maintenance in 
these communities. This likelihood is consistent with pre-
vious studies of OJC-associated shigellosis, which suggest 
that transmission is largely driven by communal childcare 
arrangements in a host population that is young and densely 
structured (19,20,22).
This study documents the speed with which MDR en-
teric bacteria can transmit intercontinentally through travel 
within a geographically dispersed, but closely linked, com-
munity. Awareness of this mode of sustained, geographi-
cally noncontiguous transmission must inform public health 
practice, including targeted control and reduction of conse-
quences of the pathogen through developing effective rela-
tionships with affected communities; identifying specific risk 
factors; and designing, piloting, and eventually implement-
ing specific culturally appropriate interventions with the par-
ticipation and support of the community while avoiding stig-
matization. Effective ongoing surveillance is also vital, and 
we demonstrated the resolution required for that purpose and 
the need for effective data sharing to track these otherwise 
silent transmission phenomena. Furthermore, the repeated 
application of high-resolution tools supports identification of 
parallels and contrasts with previous genomic epidemiology 
studies, supporting construction of a complete picture of the 
global transmission of AMR enteric pathogens, advancing 
our position for tackling this global public health issue.
Acknowledgments
We thank David Harris and WTSI sequencing and informatics 
teams for coordinating sample management, sequencing, and 
automated analyses. 
K.S.B. is in receipt of a Wellcome Trust Postdoctoral Training 
Fellowship for Clinicians (106690/A/14/Z) and all WTSI authors 
are supported by Wellcome Trust grant number 098051. This 
study was also aided by the European Union Seventh Framework 
Programme (FP7/2007–2013) under grant agreement 261472 
‘STOPENTERICS’. The French National Reference Center for 
E. coli, Shigella and Salmonella is co-funded by the Institut de 
Veille Sanitaire. The Unité des Bactéries Pathogènes Entériques 
belongs to the Integrative Biology of Emerging Infectious  
Diseases Laboratory of Excellence funded by the French  
Government Investissement d’Avenir programme (grant no. 
ANR-10-LABX-62-IBEID).
Dr. Baker is a veterinarian researcher working as a research fel-
low at the Wellcome Trust Sanger Institute and the University of 
Liverpool and has also been awarded a Wellcome Trust  
Postdoctoral Clinical Research Training Fellowship. Her 
research interests include genomic epidemiology of enteric 
pathogens and the dynamics of antimicrobial resistance in  
bacterial populations.
References
  1. World Health Organization. WHO Global strategy for containment 
of antimicrobial resistance. Switzerland: The Organization; 2001.
  2. Centers for Disease Control and Prevention. Antibiotic resistance 
threats in the United States, 2013. Atlanta: US Department of 
Health and Human Services; 2013 [cited 2016 May 26].  
http://www.cdc.gov/drugresistance/threat-report-2013/index.html
  3. van der Bij AK, Pitout JD. The role of international travel in the 
worldwide spread of multiresistant Enterobacteriaceae.  
J Antimicrob Chemother. 2012;67:2090–100. http://dx.doi.
org/10.1093/jac/dks214
  4. GBD 2013 Mortality and Causes of Death Collaborators.  
Global, regional, and national age-sex specific all-cause and  
cause-specific mortality for 240 causes of death, 1990–2013: a 
systematic analysis for the Global Burden of Disease Study 2013.  
Lancet. 2015;385:117–71. http://dx.doi.org/10.1016/S0140-
6736(14)61682-2
  5. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, 
Sansonetti PJ, et al. Global burden of Shigella infections:  
implications for vaccine development and implementation of  
control strategies. Bull World Health Organ. 1999;77:651–66.
  6. Kothary MH, Babu US. Infective dose of foodborne pathogens in 
volunteers: a review. J Food Saf. 2001;21:49–68.  
http://dx.doi.org/10.1111/j.1745-4565.2001.tb00307.x
  7. Vinh H, Baker S, Campbell J, Hoang NV, Loan HT, Chinh MT,  
et al. Rapid emergence of third generation cephalosporin resistant 
Shigella spp. in Southern Vietnam. J Med Microbiol. 2009;58:281–
3. http://dx.doi.org/10.1099/jmm.0.002949-0
  8. Ashkenazi S, Levy I, Kazaronovski V, Samra Z. Growing  
antimicrobial resistance of Shigella isolates. J Antimicrob  
Chemother. 2003;51:427–9. http://dx.doi.org/10.1093/jac/dkg080
  9. Kuo CY, Su LH, Perera J, Carlos C, Tan BH, Kumarasinghe G,  
et al. Antimicrobial susceptibility of Shigella isolates in eight  
Asian countries, 2001–2004. J Microbiol Immunol Infect. 2008; 
41:107–11. 
10. Vrints M, Mairiaux E, Van Meervenne E, Collard JM, Bertrand S. 
Surveillance of antibiotic susceptibility patterns among Shigella 
sonnei strains isolated in Belgium during the 18-year period  
1990 to 2007. J Clin Microbiol. 2009;47:1379–85.  
http://dx.doi.org/10.1128/JCM.02460-08
11. Livio S, Strockbine NA, Panchalingam S, Tennant SM,  
Barry EM, Marohn ME, et al. Shigella isolates from the global 
enteric multicenter study inform vaccine development. Clin Infect 
Dis. 2014;59:933–41. http://dx.doi.org/10.1093/cid/ciu468
12. Bangtrakulnonth A, Vieira AR, Lo Fo Wong DM,  
Pornreongwong S, Pulsrikarn C, Sawanpanyalert P, et al. Shigella 
from humans in Thailand during 1993 to 2006: spatial-time trends 
in species and serotype distribution. Foodborne Pathog Dis. 
2008;5:773–84. http://dx.doi.org/10.1089/fpd.2008.0109
13. Qiu S, Xu X, Yang C, Wang J, Liang B, Li P, et al. Shift in  
serotype distribution of Shigella species in China, 2003–2013. Clin 
Microbiol Infect. 2015;21:252.e5–8. http://dx.doi.org/10.1016/j.
cmi.2014.10.019 
14. Banga Singh KK, Ojha SC, Deris ZZ, Rahman RA. A 9-year study 
of shigellosis in Northeast Malaysia: antimicrobial susceptibility  
and shifting species dominance. J Public Health (Bangkok). 
2011;19:231–6. http://dx.doi.org/10.1007/s10389-010-0384-0
15. Vinh H, Nhu NT, Nga TV, Duy PT, Campbell JI, Hoang NV, et al. 
A changing picture of shigellosis in southern Vietnam: shifting  
species dominance, antimicrobial susceptibility and  
clinical presentation. BMC Infect Dis. 2009;9:204.  
http://dx.doi.org/10.1186/1471-2334-9-204
16. Holt KE, Baker S, Weill FX, Holmes EC, Kitchen A, Yu J, et al. 
Shigella sonnei genome sequencing and phylogenetic analysis 
indicate recent global dissemination from Europe. Nat Genet. 
2012;44:1056–9. http://dx.doi.org/10.1038/ng.2369
	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	22,	No.	9,	September	2016	 1553
17. Holt KE, Thieu Nga TV, Thanh DP, Vinh H, Kim DW, Vu Tra MP,  
et al. Tracking the establishment of local endemic populations 
of an emergent enteric pathogen. Proc Natl Acad Sci U S A. 
2013;110:17522–7. http://dx.doi.org/10.1073/pnas.1308632110
18. Centers for Disease Control and Prevention. Multistate outbreak 
of Shigella sonnei gastroenteritis—United States. MMWR Morb 
Mortal Wkly Rep. 1987;36:440–2, 448–9. 
19. Cohen D, Bassal R, Goren S, Rouach T, Taran D, Schemberg B, 
et al. Recent trends in the epidemiology of shigellosis in Israel. 
Epidemiol Infect. 2014;142:2583–94. http://dx.doi.org/10.1017/
S0950268814000260
20. Garrett V, Bornschlegel K, Lange D, Reddy V, Kornstein L, 
Kornblum J, et al. A recurring outbreak of Shigella sonnei among 
traditionally observant Jewish children in New York City: the 
risks of daycare and household transmission. Epidemiol Infect. 
2006;134:1231–6. http://dx.doi.org/10.1017/S0950268806006182
21. Boumghar-Bourtchai L, Mariani-Kurkdjian P, Bingen E, Filliol I, 
Dhalluin A, Ifrane SA, et al. Macrolide-resistant Shigella sonnei. 
Emerg Infect Dis. 2008;14:1297–9. http://dx.doi.org/10.3201/
eid1408.080147
22. De Schrijver K, Bertrand S, Gutierrez Garitano I,  
Van den Branden D, Van Schaeren J. Outbreak of Shigella sonnei 
infections in the Orthodox Jewish community of Antwerp,  
Belgium, April to August 2008. Euro Surveill. 2011;16:pii:19838. 
23. McDonnell J, Dallman T, Atkin S, Turbitt DA, Connor TR,  
Grant KA, et al. Retrospective analysis of whole genome  
sequencing compared to prospective typing data in further  
informing the epidemiological investigation of an outbreak of 
Shigella sonnei in the UK. Epidemiol Infect. 2013;141:2568–75. 
http://dx.doi.org/10.1017/S0950268813000137 
24. Sobel J, Cameron DN, Ismail J, Strockbine N, Williams M,  
Diaz PS, et al. A prolonged outbreak of Shigella sonnei infections 
in traditionally observant Jewish communities in North America 
caused by a molecularly distinct bacterial subtype. J Infect Dis. 
1998;177:1405–9. http://dx.doi.org/10.1086/517825
25. Ashton PM, Baker KS, Gentle A, Wooldridge DJ, Thomson NR, 
Dallman TJ, et al. Draft genome sequences of the type strains  
of Shigella flexneri held at Public Health England: comparison  
of classical phenotypic and novel molecular assays with whole 
genome sequence. Gut Pathog. 2014;6:7.  
http://dx.doi.org/10.1186/1757-4749-6-7 
26. Quail MA, Kozarewa I, Smith F, Scally A, Stephens PJ,  
Durbin R, et al. A large genome center’s improvements to  
the Illumina sequencing system. Nat Methods. 2008;5:1005–10. 
http://dx.doi.org/10.1038/nmeth.1270
27. Quail MA, Otto TD, Gu Y, Harris SR, Skelly TF, McQuillan JA, 
et al. Optimal enzymes for amplifying sequencing libraries. Nat 
Methods. 2011;9:10–1. http://dx.doi.org/10.1038/nmeth.1814
28. Baker KS, Dallman TJ, Ashton PM, Day M, Hughes G, Crook 
PD, et al. Intercontinental dissemination of azithromycin-resistant 
shigellosis through sexual transmission: a cross-sectional study. 
Lancet Infect Dis. 2015;8:933–21. http://dx.doi.org/10.1016/S1473-
3099(15)00002-X
29. Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA,  
Bentley SD, et al. Rapid phylogenetic analysis of large samples of  
recombinant bacterial whole genome sequences using Gubbins.  
Nucleic Acids Res. 2015;43:e15. http://dx.doi.org/10.1093/nar/gku1196
30. Stamatakis A. RAxML-VI-HPC: maximum likelihood-based 
phylogenetic analyses with thousands of taxa and mixed models. 
Bioinformatics. 2006;22:2688–90. http://dx.doi.org/10.1093/bioin-
formatics/btl446
31. Drummond AJ, Rambaut A. BEAST: Bayesian evolutionary  
analysis by sampling trees. BMC Evol Biol. 2007;7:214.  
http://dx.doi.org/10.1186/1471-2148-7-214
32. Rambaut A, Lam TT, Max Carvalho L, Pybus OG. Exploring  
the temporal structure of heterochronous sequences using  
TempEst (formerly Path-O-Gen). Virus Evolution. 2016;2:1.  
http://dx.doi.org/10.1093/ve/vew007 
33. Carattoli A, Zankari E, Garcia-Fernandez A, Voldby Larsen M, 
Lund O, Villa L, et al. In silico detection and typing of plasmids 
using PlasmidFinder and plasmid multilocus sequence typing. 
Antimicrob Agents Chemother. 2014;58:3895–903.  
http://dx.doi.org/10.1128/AAC.02412-14
34. Carver TJ, Rutherford KM, Berriman M, Rajandream MA,  
Barrell BG, Parkhill J. ACT: the Artemis Comparison Tool.  
Bioinformatics. 2005;21:3422–3. http://dx.doi.org/10.1093/bioin-
formatics/bti553
35. Ye C, Lan R, Xia S, Zhang J, Sun Q, Zhang S, et al. Emergence  
of a new multidrug-resistant serotype X variant in an epidemic  
clone of Shigella flexneri. J Clin Microbiol. 2010;48:419–26.  
http://dx.doi.org/10.1128/JCM.00614-09
Address for correspondence: Nicholas R. Thomson, Wellcome  
Trust Sanger Institute, Hinxton, Cambridgeshire, CB10 1SA, UK;  
email: nrt@sanger.ac.uk 
Visit our website to listen: http://www2c.cdc.gov/podcasts/player.asp?f=8642667
EID Podcast: Nipah Virus Transmission from Bats to Humans 
Associated with Drinking Traditional Liquor Made from  
Date Palm Sap, Bangladesh, 2011–2014
Nipah virus (NiV) is a paramyxovirus, and Pteropus spp. bats are the natural 
reservoir. From December 2010 through March 2014, hospital-based 
encephalitis surveillance in Bangladesh identified 18 clusters of NiV 
infection. A team of epidemiologists and anthropologists investigated 
and found that among the 14 case-patients, 8 drank fermented date 
palm sap (tari) regularly before their illness, and 6 provided care to 
a person infected with NiV. The process of preparing date palm trees 
for tari production was similar to the process of collecting date palm 
sap for fresh consumption. Bat excreta was reportedly found inside 
pots used to make tari. These findings suggest that drinking tari is 
a potential pathway of NiV transmission.
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